Avadel Pharmaceuticals plc (AVDL)

Etorro trading 970x250

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company’s lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, 2

Avadel Pharmaceuticals plc News and around…

Latest news about Avadel Pharmaceuticals plc (AVDL) common stock and company :

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
19 Oct, 2021 FinancialContent

Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market ...

Avadel Presents New Data Supporting Clinical Benefit with Once-at-Bedtime FT218 and Preference for Once-Nightly Dosing in Patients with Narcolepsy at CHEST 2021
19 Oct, 2021 Yahoo! Finance

- Post-hoc responder analyses demonstrated a significantly greater proportion of patients receiving FT218 experienced reductions in weekly cataplexy attacks and improvement in mean sleep latency compared to placebo - - Discrete choice experiment demonstrated that the strongest relative driver of overall product choice was number of doses with once-nightly preferred versus twice-nightly dosing regimen between sodium oxybate - DUBLIN, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (N

46 Biggest Movers From Yesterday
19 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avadel Pharmaceuticals plc - AVDL
18 Oct, 2021 Yahoo! Finance

New York, New York--(Newsfile Corp. - October 18, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Avadel Pharmaceuticals plc ("Avadel" or the "Company") (NASDAQ: AVDL). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Avadel and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about ...

Why Shares of Avadel Are Sinking Today
18 Oct, 2021 FinancialContent

A key regulatory decision is overdue, leaving shareholders to wonder when it might arrive.

34 Stocks Moving In Monday's Mid-Day Session
18 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints ...

First Week of June 2022 Options Trading For Avadel Pharmaceuticals (AVDL)
18 Oct, 2021 FinancialContent

Investors in Avadel Pharmaceuticals PLC (AVDL) saw new options become available this week, for the June 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

12 Health Care Stocks Moving In Monday's Pre-Market Session
18 Oct, 2021 FinancialContent

Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market ...

Avadel Shares Fall As FDA Pushes Approval For Its Narcolepsy Treatment Candidate
18 Oct, 2021 FinancialContent

TheFDA has notifiedAvadel Pharmaceuticals plc(NASDAQ: AVDL) that the review of its marketing application for FT218 ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
18 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! I hope the weekend served you well because we've got pre-market stock movers to start off Monday with! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
18 Oct, 2021 FinancialContent

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market ...

21 Stocks Moving in Monday's Pre-Market Session
18 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results ...

51 Biggest Movers From Friday
18 Oct, 2021 FinancialContent

Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on ...

Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with Narcolepsy
15 Oct, 2021 Yahoo! Finance

DUBLIN, Ireland, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that the U.S. Food and Drug Administration (FDA) notified the company that the review of the New Drug Application (NDA) for FT218 is still ongoing, and action will likely not be taken in October. The FDA informed the company that there are no information requests at this time and a new target action date will be provided as

12 Health Care Stocks Moving In Friday's Pre-Market Session
15 Oct, 2021 FinancialContent

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market ...

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
15 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
15 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's the final day of the week and we're starting the end with a look at the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

22 Stocks Moving in Friday's Pre-Market Session
15 Oct, 2021 FinancialContent

Gainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. ...

15 Stocks Moving in Monday's Pre-Market Session
11 Oct, 2021 FinancialContent

Gainers Trevi Therapeutics, Inc. (NASDAQ: TRVI) rose 32.5% to $1.59 in pre-market trading after the company filed Friday to ...

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
10 Oct, 2021 FinancialContent

Biotech stocks retreated in the week endingOct. 8, extending losses for the third straight week. Some of the selling in the space ...

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

2 Healthcare Stocks With Big Catalysts in October
03 Oct, 2021 Yahoo! Finance

Healthcare stocks have a reputation of keeping investors on their toes. The possibility of surging price action, or conversely, earth shattering drops is very real, but these movements can come and go in the blink of an eye. As a result, these stocks need constant monitoring ahead of key catalysts, as they can affect the price dramatically. Additionally, the price movement is usually dependent on one of the following: either a regulatory approval or trial data. Once either is announced to the pu

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
01 Oct, 2021 FinancialContent

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug ...

Implied Volatility Surging for Avadel (AVDL) Stock Options
29 Sep, 2021 Yahoo! Finance

Investors need to pay close attention to Avadel (AVDL) stock based on the movements in the options market lately.

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
29 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
28 Sep, 2021 FinancialContent

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. ...

Needham Initiates Coverage With Buy For This Narcolepsy Player
23 Sep, 2021 FinancialContent

Needhamhas initiatedAvadel Pharmaceuticals Plc(NASDAQ: AVDL) coverage with a Buy rating and $17 price ...

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
23 Sep, 2021 FinancialContent

Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:WMG) from Equal-Weight to Overweight. ...

Avadel Recognizes World Narcolepsy Day and Announces New Data Presentations from Pivotal Phase 3 REST-ON Trial of FT218 at Upcoming Conference
20 Sep, 2021 FinancialContent
We Did The Math IBBQ Can Go To $33
15 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Nasdaq Biotechnology ETF (IBBQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $32.82 per unit.

Avadel Pharmaceuticals plc (AVDL) is a NASDAQ Common Stock listed in , ,

970x250